Cargando…
Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients' survival when delivered as usual care
BACKGROUND: Randomized clinical trials showed the benefit of pharmacological and revascularization treatments in secondary prevention of myocardial infarction (MI), in selected population with highly controlled interventions. The objective of this study is to measure these treatments' impact on...
Autores principales: | Vanasse, Alain, Courteau, Josiane, Niyonsenga, Théophile |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473199/ https://www.ncbi.nlm.nih.gov/pubmed/16674817 http://dx.doi.org/10.1186/1471-2261-6-21 |
Ejemplares similares
-
Access to myocardial revascularization procedures: Closing the gap with time?
por: Vanasse, Alain, et al.
Publicado: (2006) -
Neighbourhood immigration, health care utilization and outcomes in patients with diabetes living in the Montreal metropolitan area (Canada): a population health perspective
por: Vanasse, Alain, et al.
Publicado: (2015) -
Cardiovascular safety of celecoxib in acute myocardial infarction patients: a nested case-control study
por: Vanasse, Alain, et al.
Publicado: (2009) -
Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec
por: Vanasse, Alain, et al.
Publicado: (2005) -
Spatial variation in the management and outcomes of acute coronary syndrome
por: Vanasse, Alain, et al.
Publicado: (2005)